Article on the results of phase II study with MesoPher in resected pancreatic cancer published in MedNous, June 2022

Amphera is happy to announce that an article on the results of our phase II study with MesoPher in resected pancreatic cancer has been published in MedNous in June 2022.

Scroll to Top